Share-Based Compensation - Schedule of Stock Options Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands |
6 Months Ended |
|
Aug. 01, 2020
USD ($)
$ / shares
shares
|
| Number of Shares |
|
| Outstanding at beginning of period (in shares) | shares |
3,650
|
| Granted (in shares) | shares |
0
|
| Exercised (in shares) | shares |
0
|
| Forfeited or expired (in shares) | shares |
(263)
|
| Outstanding at end of period (in shares) | shares |
3,387
|
| Expected to vest at end of period (in shares) | shares |
2,009
|
| Exercisable at end of period (in shares) | shares |
1,313
|
| Grant Date Weighted Average Exercise Price Per Share |
|
| Outstanding at beginning of period (in USD per share) | $ / shares |
$ 7.67
|
| Granted (in USD per share) | $ / shares |
0
|
| Exercised (in USD per share) | $ / shares |
0
|
| Forfeited or expired (in USD per share) | $ / shares |
18.04
|
| Outstanding at end of period (in USD per share) | $ / shares |
6.87
|
| Expected to vest at end of period (in USD per share) | $ / shares |
2.70
|
| Exercisable at end of period (in USD per share) | $ / shares |
$ 13.45
|
| Weighted-Average Remaining Contractual Life (in years) |
|
| Outstanding at end of period |
7 years 4 months 24 days
|
| Expected to vest at end of period |
8 years 10 months 24 days
|
| Exercisable at end of period |
4 years 10 months 24 days
|
| Aggregate Intrinsic Value |
|
| Outstanding at end of period | $ |
$ 0
|
| Expected to vest at end of period | $ |
0
|
| Exercisable at end of period | $ |
$ 0
|